From Primary MSC Culture of Adipose Tissue to Immortalized Cell Line Producing Cytokines for Potential Use in Regenerative Medicine Therapy or Immunotherapy
For twenty-five years, attempts have been made to use MSCs in the treatment of various diseases due to their regenerative and immunomodulatory properties. However, the results are not satisfactory. Assuming that MSCs can be replaced in some therapies by the active factors they produce, the immortali...
Guardado en:
Autores principales: | Maria Paprocka, Honorata Kraskiewicz, Aleksandra Bielawska-Pohl, Agnieszka Krawczenko, Leszek Masłowski, Agnieszka Czyżewska-Buczyńska, Wojciech Witkiewicz, Danuta Dus, Anna Czarnecka |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b668c22bd5e444d4bba64aabead19f1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
HATMSC Secreted Factors in the Hydrogel as a Potential Treatment for Chronic Wounds—In Vitro Study
por: Honorata Kraskiewicz, et al.
Publicado: (2021) -
Immortalizing Cells for Human Consumption
por: Emily Soice, et al.
Publicado: (2021) -
Tumorigenic Aspects of MSC Senescence—Implication in Cancer Development and Therapy
por: Slavko Mojsilović, et al.
Publicado: (2021) -
MSC transplantation: a promising therapeutic strategy to manage the onset and progression of diabetic nephropathy
por: Ezquer,Marcelo E, et al.
Publicado: (2012) -
MSC therapy for inflammatory bowel disease
por: Mikhail A. Konoplyannikov, et al.
Publicado: (2021)